PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2019-10-17

Date Title Company
17-Oct-2019 DURECT to Present at Two Upcoming NASH Investor Conferences DURECT Corporation
17-Oct-2019 Janssen Presents New Four-Year TREMFYA® (guselkumab) Data Demonstrating Maintained Rates of Skin Clearance in Adult Patients with Moderate to Severe Plaque Psoriasis Janssen Pharmaceutical Companies of Johnson & Johnson
17-Oct-2019 AIVITA Biomedical Announces Publication Comparing Clinical Outcomes in Patients Treated with AIVITA's Immunotherapy and Other Immunotherapies AIVITA Biomedical
17-Oct-2019 SOFINNOVA PARTNERS RAISES €333 MILLION CAPITAL IX EARLY-STAGE HEALTHCARE FUND Sofinnova Partners
17-Oct-2019 Bimekizumab Phase 3 Psoriasis Study Meets All Endpoints, Achieving Significantly Greater Efficacy Versus Placebo and Ustekinumab UCB
17-Oct-2019 Minoryx Therapeutics receives FDA Orphan Drug Designation for leriglitazone in Friedreich’s Ataxia Minoryx Therapeutics
17-Oct-2019 Programme Highlights Released for SMi’s 11th RNA Therapeutics Conference SMI
17-Oct-2019 Orgenesis announces co-development agreement with Accellix Orgenesis
17-Oct-2019 Genomics plc welcomes Professor Sir Mike Richards’ Independent Review of Adult Screening Programmes in England Genomics plc
17-Oct-2019 Amarna Therapeutics Raises €10 Million to Progress Lead Development Candidate into Clinical Trials and Appoints a New Supervisory Board Amarna Therapeutics
17-Oct-2019 Foamix Announces FDA Acceptance of its New Drug Application for FMX103 Minocycline Foam for the Treatment of Moderate-to-Severe Papulopustular Rosacea Foamix Pharmaceuticals Ltd.
17-Oct-2019 Pratia Teams with VirTrial to Become First ‘Virtual Trial Capable’ Site Network in Europe Pratia
17-Oct-2019 Biocair Hosts Brexit Briefing And Workshop In London Biocair
17-Oct-2019 FamiCord Group’s Treatment Program is a Breakthrough in the Use of the Patients’ Own Stem Cells FamiCord Group
17-Oct-2019 Clovis Oncology Announces Rubraca®▼ (rucaparib) Now Available for Women with Relapsed Ovarian Cancer in England Through the Cancer Drugs Fund Clovis Oncology, Inc
17-Oct-2019 Tildrakizumab confirms its long-term efficacy and safety with the longest IL23p19 data available Almirall
17-Oct-2019 Syneos Health Wins Society for Clinical Research Sites Eagle Award for Third Consecutive Year Syneos Health
17-Oct-2019 The medication lifecycle ~ Ensuring patient safety every step of the way ~ Valley Northern Limited
17-Oct-2019 Pneumagen Demonstrates Preclinical Proof-of-Concept in Oncology for Neumonco, a Novel Carbohydrate Binding Module Pneumagen Ltd
17-Oct-2019 Q2i Awarded NIH/NIDA Grant to Develop and Evaluate Loyalty/Reward-based Digital Technology to Increase Medication Adherence for Substance Use Disorder after an ED Visit Q2i